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slant thrombosis (SAT) and ~rdiac events were assessed in 160 pts, All pts 
received a single Palmaz-Sthatz sfont because of stable angina and u de 
nero coronary lesion. The protoCOl outlines that pts meeting the IVUS criteria 
of optimal stent expansion only receive ASA > 100 rag, while those not 
meeting the criteria receive ASA, oral and iv ant+coagulation after alenting. 
83% of the pts received ASA (of whom 17% should have been treated with 
anticoagulants ~ protocol violation) and 17=/= received systemio ant+coagu- 
lation. A total count of events and ranking according to the worst category 
analysis is shown in Table 1, 
This muiticentri¢ study confirms that stents can indeed be safely implanted 
without he institution of systemic anticoegulation. 
9:45 
~ - ~  Integrelin for Coronary Artery Stenting Emergency 
James P, Zidar, Kevin R. Kruse, Mark C. Thel, Dean Kereiakas, Joseph 
B, Muhlestsin, Chades J. Davidson, Paul S, Teirstein, Alan Tenaglia, Steven 
J. Yakubov, Jeffrey J. Popma, Jean-Francois Tanguay, Michael M. Kilt, Todd 
J. Lorenz, James E. Tcheng, A, Michael Lincoif, Robert M. Calliif, Eric 
J. Topoi for the IMPACT II Investigators. Duke University, Ourham, NC 
TO assess the potential benefit of GP lib/Ilia inhlbitors with COrOnary slant- 
ing, we studied 160 patients who required alents for true/threatened closure 
in the IMPACT it trial. In this trial of 4010 patients, no stents were placed 
eleclivaly by protocol design. A composite end point of death, MI, urgent 
repeat intervention or CABG was compared between the slant patients in 
the placebo arm vs. ptS randomized to one of two Integrelin doses. Baseline 
cheracleristi~ were similar betweer~ tho stent and n0n.stented groups. En- 
rollment status was characterized as high risk in 45% of patients in the stent 
group vs 41% in the non-slant group. Most (87%) slant patients received a 
Cook stent and were discharged on warfarin. 
Endpoints at 30 days! Integrefln (  = 101 ) Placebo (n = 59) p 
composite ndpeint 31% 49%. 0,021 
MI 16% 32% 0.017 
Urgent CABG ?% 8%,* 0,723 
Urgsnt repeal intervention G% 8% 0.546 
Death 2% 1.7% 0.897 
Major bleeding complication 21% 21% 0.956 
Conclusions: The high event rates in both groups reflect the "true bailout" 
indication for stsnting, Integrelin improves 30 day clinical outcome by reduc- 
ing the risk of MI in patients requiring slants after failed PTCA, without an 
increase in bleeding. This suggests the importance of GP lib/Ilia inhibition in 
coronary slanting. 
Ang lop laaty  and Restenos is :  Ro le  o f  Stents  
Tuesday, March 26, 1996, 8:30 a .m. -10:00 a.m. 
Orange County  Convention Center, Room 314 
8:30 
~ l s  Them Need for Intravsscular Ultrasound After 
High-Pressure Dilatations of  Palmaz-Schatz Stente 
Kathioen M. Allen, Caned Undemlr. Alexander 8haknovich. Jeffrey Moses. 
Janet StE!n, Edward Kreps. Lsnox Hill Hospital, New York, NY 
Use of intrevescular ullre, sound (IVU,~) in conjunction with angiegraphio as- 
sessment of Palmaz-Schalz slants (PSSs) provided the rationale for routine 
post.deployment high pressure dilatation (HPD) of P,,~Ss. To address the 
question of whether outine NPD obviates the need for IVUS, we reviewed 
IVUS and quarditatlve angi0graphic (QCA) data in 91 pts with 96 lesions. 
HPO was performed in all pts (mean i:r(essure 16.7 4-1.6 ATM; range 14,-20 
ATM) with 1-1.1 balloon; artery ratio, Further imprevements were neces- 
ss~ In 4,5/96 vessels after post-HPD IVUS secondary to suboptimal stent 
geometry (32), I~Otn~ing tissue (5), and dissection/eddifional sten0sas (8). 
8 vessels requira~, additional PSSs and 37 further HPDs (17 with ~ same 
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and 2G with a ;arger balloon). IVUS (rt = 45) ~r~J ~A (n =* 30) wo~ repasted 
after each HPD. 
Pest HPD Final p value 
QGA MLO (ram) 2.66 ± 0.54 2.92 :E 0.50 0,055 
QCA stenoais % 5.95 ,.I- 8,86 -1.82,9.98 0,0007 
IVU8 MLD (ram) 2.81:1:0A1 3.10 + 0.39 0,001 
IVUS stenosis % 19.6 ± 9.2 9.85 :h 12,2 0,0002 
CSA (mm2) 7.5 ± 1.SS 8.97 + 2.03 0,001 
.Symmetry , 0.aS + 0.07 0.gO :~ 0.062 0,21 
Conclusions: In nearly half of P,~,Ss, IVUS folfowing HPD identified sub- 
optimal results which were improved with further intervention, A prospective 
randomized trial will be necessary to verify if this strategy alters clinical 
outcome. 
8:45 
~ Inlluence of  Size on the Late Restenotic Vessel 
Process After Successful  Stent Implantation 
Naeya Hamasaki, Hldeyuki Nasaka, Takeshi Kimure, Himyoshi Yok0i, 
Takashi Tamura, Yashihiro Sawada. Masakiyo Nobuysshi. Kitakyushu, 
Kokura Memorial Hospital, Japan 
The purpose of the present study was to investigate the influence of vessel 
size on late angiogrephic outcome after successful single stent placement, 
The study population compdsed 547 consecutive lesions implanted native 
artedes [Palmatz*$ohalz 436, Gianturco-Roubin 50, Cottlis. 61] and satis- 
factodc angiogrephic analysis before and after slanting and at 3 or 6 months 
follow-up (FUP) from a single center (Feb. 1990-Feb. 1995). 
Vassal size < 3.0 mm 3,0,-3.5 mrn > 3,5 mm 
Acute gain 1.86 + 0.67 2,05 + 0.44 2.22 :~ 0,55 P - 0.0001 
Late loss  0.89+0.67 0.97:1:0.64 0,81 :~0,65 P,= 0,56 
MLD FLIP 1.76±0,63 2.02:b 0,6 2,40~0.63 P ,~ 0,0001 
.I Re la t iVe  loss  i 
I "4 V~.RSIEL SIZE | 
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Vessel size was found to be exert a significant positive influence on MLD 
at FUP and an equally negative elfect on loss by muifivadable analysis (p < 
0.001). The relative gain/loss relationships within the lesion groups showed 
that it does not vary with vessel size, In conclusion, vessel size ifse~11 does not 
influence the restenosls process, which appears to be determined mainly by 
the degree of luminal increase achieved at slanting, regardless of the veSsel 
size. 
9 :00 
~ Dlatrlbutlon of  Tissue Growth In Palmaz-Schatz 
Stents: Ina l~t ts  F rom a Serial Intravascular 
Ultrasoun¢l'~fudy 
Ralner Hoffman, Gary S. Mlntz, Jeffrey J. Popma, Augusto D. Pichard, 
Lowell R Seller, Kenneth M. Kent, Roxana Mehreo, Martin B. Leon. 
Washington HospitaI Center, Washington, DC 
Previous studies have suggested that Instant restenosis is (1) due to inttmal 
hypelplasia and (2) occurs most frequently at the central articulation (CA) of 
Palmaz-Schatz slants. To understa~ this process, we compared Sedal {post- 
intervention and follow-up (F/U 5.4 4- 3.8 rues)} Intravasculm ultrasound 
studies in 104 slants implanted into 49 native and 39 SVG lesions, Lumerl 
and slant areas (in mm z) were measured; plaque (slant-lumen) area, late 
lumen toss (&lumen area) and tissue growth (&plaque area) were calculated 
for the edges, body, and CA of all slants: 
Edges., Body CA p(ANOVA) 
Post sterd area 10.t +4.1 9.5 • 3.6 9.6 :E 4.0 0.0005 
RU slant area 9.9+1:4.1 9.8 ~3.8 9,4+9.8 0.01 
Post lumen area  10.0+4.0 9.5±3.6 9.1:t:3.9 <0.000t 
F/U lumen area 7.1 :E3.9 8.5:1:3.6 6.0+4.1 <0.CO0t 
Post plaque area 0.0 + 0.1 0.0.4- 0.0 0.5 + 1.1 <0.0001 
F/U ¢A~ue ares 2.8:1:2.0 3.0 :I: 2.0 3,4 + 2.6 <0.0001 
Late lumen lo=~ 2.8:1:1.6 3.0:1:2.0 3,1 +25 NS 
T~s~gmwth 2.6 + 1.9 2.9 ± 2.0 2,8 + 2.5 NS 
The kntten 8t the cat,rat artJctdatton Is smaJler than at the bady or ¢:~v~ e! 
the rant besause of a s,g~y sma,er stem a~ea nd s ~  Wokmse 
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ot bssue through the central articulation. Subsequent accumulation of nestn- 
timal tissue is uniformly distributed througho'Jt he slant. We conclude: Serial 
lntravascular ultrasound imaging shows that restenosis at the CA (compared 
to the edges or body) of Palmaz-Schatz sfants Is the result of a smaller Initial 
lumen (smaller sfant area and tissue prolapse) and not due to a prupensily 
for Ip.c~'eased neointimal tissue accumulation. 
9:15 
~ REsMnosla STent {REST) Study: Randomized ~ la l  
Comparing Slanting and Bal loon Angloplasty for  
~matment of  Restenosis After Balloon Angloplasty 
Ralmund Erbel, Michael Haude, Hans W. H0pp, Carlos Macaya, 
Maeakiyo Nobwoshi, Peter Pabst, Martin Sigmund, Haka~ Emanuetsson, 
Bah'el Heublein, Wolfgang Rutsch, Gunhlld Hero.ann, on behalf of the 
REST Study Group. Dept. of Cardiology, University Essen, Germany 
The REST-Study is a multicenfar randomized trial comparing the implantation 
of a single Palmaz-Schatz sfant vs. balloon a~gioplasty (PTCA) in i~tianls 
(pts) with restenosis in native coronary arteries, Pts enrelmem (n = 4Q0) 
was completed in May lg95. According to the protocol, an intenm analyeis 
acute and 6.month follow-up (FU) was performed on fhe first 123 pts. For 
quantitative coronary angiography, a CMS system (Medis, Netherlands) was 
used to assess p~'e, post Intervention and at 6 month FU minimal uminal 
diameter. 
S~emeeF[n - - ~r _PTGA {. - 87} 
Reference dismeter ( am) 3.01 d: 0.32 3.04.;- 0.26 
MLD {turn) p~-intervent!on 1.25:E 0.44 1.20 :t: 0.35 
MLD (am) post-intmvention 3.12:E 0.43 2.33 + 0.57 
MLD (am) at FU 2.14 ~ 0.66 1.86 ± 0.56 
Reslenosis with rein~'erve~tion 11.7"/. 37% 
Acute thrombosis I.L~', 1.2% 
Subacule thrombosis 3.5% - 
Emergency GABG - - 
Blee~ing "12.3% 4.6% 
Death - - 
The interim analysis of the REST-Sfudy demonstrates (1) favorable results 
concerning acule and FU angiographlc lumen diameter and (2) a reduced 
restenosis rate based on necessary reinterventions for atenting comPared to 
PTCA. 
9:30 
~ Stanting In Chronk: Coronary Occlusion (SICCO): A 
Multicenter, Randomized, Controlled Study 
Per A. Sirnes, Svsin Golf, Yngvar Myreng, Per Mo/Isfad, Per Albertsson, 
H6kan Emanueisson~ Magne Brakka, Arild Mangschau, Knut Endresen. 
John Kjekshus for the SICCO Study Group. Fairing Heart Clinic, Felting, 
No~way 
Angicplasty of chronic cerenaP/occlusions (CCO) carries a high recurreeo~ 
rata. We randomized 119 pts, (58 .t- 11 years) after initial successful re. 
canalizatiori of CCO (duratiOn >_ 2 weeks, median 18 weeks, 33% TIMI-1 
occlusions) to conventional PTCA or implantation of Palmaz-Schatz stoat. 
The target vessel was LAD in 39%, LCX in 11%, and RCA in 50',,,. C~ronmy 
angtograms at baseline (after PTCA) and at 6 months foll0w-up examination 
were analyzed quantitatively, 
Analysis of 91 pts. who had completed follow-up by Sap. 95 showed a 
res|e~~s!s {> 50%) rate of 73% in the PTCA group vs. 33% in the stent group 
(p = 0.0001). Reeoctuslon rate was 24% vs. 15% (p = 0.27). Angina class, 
minimal uminal diameter (MLD) and % diameter slenesis were s lgn i f l c~ 
Improved in the stant lOtS. Them was one atant delivery failure, Major evsnts 
(AMI, PTCA or ACB in occlusion territory) occurred in 14 pts. in the PTCA 
group and 8 lOtS, in the stem group. 
PTGA (n = 36) Stem (n = 4.3) 
baseline 6 months l~asellne 6 months 
Anglns class (CCS) 2.80 ~: 0.53 1,56 -4-1.1 2.72 + 0.50 0.67 :E 0.9~" 
MLD {mm) 2.15 ~: 0.~3 1.11 :E 0.78 2.~2 :E0.51 1.78 :E 0.9~ = 
Reference diameter 3.21 :~: 0.S3 3.34 + 0.59 3.14±eA5 3.29-*-0.61 
% Otametef slSno~, 33~: 12 67=1=24 ~:f i l3 46 ~:;~* 
('p < 0.ca vs. PTCA). Fo0ow-up wn be comp~ed by De~. 95, a,d fln= results w~| be 
p~a,~YreeL 
C,o,'~uS/on: F'dmary atenting of chronic cerona~ o~usions in,Droves the 
long term clinical and ~ outcome, 
9:45 
~ S i x  Month Clinical and Angiographle Fol low-Up of  
Slanting Without Anticoagulation: The Tlclopldlne 
Aspirln Slant Evaluation (TASTE) Study 
Jean-Me c t.~tanche, Eugene P. Mc Fadden, Eric Van ~aelle, 
Nicolas Danchtn, Gillas Grellier, Mertia~ Hereon, Chd~tophe Bauters, Michel 
E, Bertrand. University of Lille, France 
Stont Implantation without anticoagulation is now standard management in 
many countries, In a prospective multicemar French study, we have followed 
Patients with stont implantation, managed with tiClopidine 500 mg and aspirin 
200 mg daJ/y, without oral anticoagulat~on. We report he anglograph/c follow- 
up in the first 105 patients who underwent successful atent implantation (TIMI 
grade 3 flow after ster4Jng without in-t~ital complica~n) and who were  
treated by protocol (ticfopidine continued for at least 1 month). Indications 
for slanting were failed angioplaaty (n ,, 50), a suboptimal result (n = 41), or 
eleotively (n = 14). 
During the 6 months after etenting I desth, unrelated to stenting, occurred 
(leukaemla): 1 asymptomaftc Patient underwent bypass surgery (referring 
physici=~ preference). "l~clopidine r lated neotr0Penia occurred in 4 Patients 
(On day 30, 30, 60, 60): allergic reactions occurred in 4 patients (all before 
day 18): t diges~ve hemonfiage (at ! month) and one gasVttis {3 months) 
oCCurred. 
At angingraphic follow-up, restenosis (> 5(P/~, StenOsis) was present in 
38 atents (36%), including 3 occlusions (3.2=/o). Intresfant redilatati0n was 
pedormed in 19 (18%) patients; dilatstion at non-stented segments in 11 
(10.4=/=) patients. 
In a population with a do~mented high risk of clinical complications tartl- 
ing managed by antipfatefet therapy alone had an excellent clinical outcome. 
Further studies are required to determine the factors associated with resteno- 
eis in this population. 
Diastolic Dysfunction: Mechanisms and 
Potential Treatment 
Tuesday, March 26, 1996, 8:30 a.m.,-10:00 ~.m. 
Orange County Convention Center, Room 230C 
8:30  
~ Improvement  Diastol ic in Pat ients of  Dysf.ncUon 
W'dh Aort ic Stenosis by Nll~roglycedn 
Christian Matter, t~_;~-~r Ma~Enov, Giuseppe Vassalli, Ot'(o M. Hess. 
Cardio~g~, Unive~ity Hospita£ Zurich, Switzerland 
Background: Diastolic dysfu~ion has been rel~ed in the majodty of pa- 
tients with left ventdcutar (LV) pressure overload hy - ,~y .  Thus, the 
purpose o1 the present study was to evaluate the effect of nitroglycerin (NTG) 
on diastolic dysfunction in I~tients (pts) wi~ severe ao~c stenosis (AS), 
Pat/ants and Meffmds: A total of 20 pts (10 AS; 10 controls, C) were 
included in the present analysis. LV hlgh-fic~elity p~ssun~; and simultaneous 
LV volumes were deterntined at rest and after intracomna~ adrnirdst~,tion f
150 pg NTG in AS pts, 7110 AS pts had diastolic (LVEOP >_ 14 mmHg) and 
4/10 had systolic (EF < 57%} dysftmctton. 
ReButs: Ejeclion tra~on (57 ~ 59%; NS), LV end~stelic volume, relax- 
afon rata, ean'y and late peak filling rate, LV end-systol/c hamber stiffness 
well as the constant of muscle slimness (9 vs. 7; NS) remained unchanged 
after NTG. LV end~astotic pressure (LVEDP), LV peak systolic pressure 
(LVSP: 204 vs. 190; p < 0.05) and LV end.diastolic ~amber stillness (ED$) 
decreased after NTG: 
LVEDP EDS 
0 . 0 ~ ~  
0 .... o.00 
0 NTG 0 NTG 
. . . . .  upper ange of corm,~lity (n= I 0) 
Corc/L~/ons; Oias folio dyb-ft.qlction iS prese~ in9110 ~s  with severe AS arid 
is improved in 7/10 ~ NTG, whereas systolic function remains unchanged. 
Thus, NTG exerts a loene~l effect on o'~stoti¢ ttmc~y/t in LV I1y~y.  
This ,eH:~n~e is ~ ~e to a vc~xlilatory (unk~ading) rather, than a 
~ract ~ effect 
